Private Equity
2 min read · 09 October 2019
3 min read · 01 October 2019
Capital raising, deal financing and talent retention will face more challenges, according to panellists at a private equity conference in London.
2 min read · 13 September 2019
2 min read · 05 September 2019
The past decade brought unprecedented change to venture capital. Today’s GP must bring together the sometimes competing goals of specialization, diversification and capitalization
6 min read · 03 September 2019
Salt Lake City-based Health Catalyst, a provider of data and analytics technology and services to healthcare organizations, has raised $182 million for its IPO after pricing its 7 million shares at $26 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "HCAT." Goldman Sachs, J.P. Morgan and William Blair are the lead underwriters. Health Catalyst's pre-IPO backers included OrbiMed, Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures.
3 min read · 25 July 2019
Friendswood, Texas-based Castle Biosciences Inc, a dermatological cancer company, has raised $64 million for its IPO after pricing its 4 million shares at $16 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "CSTL." SVB Leerink and Baird are the lead underwriters. Castle Biosciences' pre-IPO backers included Industry Ventures, HealthQuest Capital and Mountain Group Partners.
2 min read · 25 July 2019
International GPs backed more than 80% of deals by volume in first half of 2019, according to a report from industry association ASCRI.
2 min read · 23 July 2019
1 min read · 23 July 2019
The asset manager still expects to cross $100bn in total capital inflows in 2019, having already raised $64bn so far this year.
3 min read · 18 July 2019
